NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Subjects United States Remove constraint Subjects: United States

Search Results

8151. Coordinated development of antimicrobial drugs and antimicrobial susceptibility test devices: guidance for industry and Food and Drug Administration staff

8154. Intent to exempt certain unclassified medical devices from premarket notification requirements: guidance for industry and Food and Drug Administration staff

8157. Opioid use disorder: developing depot buprenorphine products for treatment

8158. Evaluation of devices used with regenerative medicine advanced therapies

8159. Considerations for the inclusion of adolescent patients in adult oncology clinical trials

8160. Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals